| Dr Robert E Weltman, MD | |
|
131 N Oakwood Ave Ste 135, Brandon, FL 33510-4629 | |
| (813) 440-5544 | |
| (813) 440-5545 |
| Full Name | Dr Robert E Weltman |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 46 Years |
| Location | 131 N Oakwood Ave Ste 135, Brandon, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720119928 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 27846-020 (Wisconsin) | Secondary |
| 207N00000X | Dermatology | 2018016397 (Missouri) | Secondary |
| 207N00000X | Dermatology | ME117123 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aqua Dermatology Of Florida, Pa | 1153390414 | 159 |
News Archive
Immunicum, which is developing cancer vaccines, has received approval from the Swedish Medical Products Agency to start its first clinical trial. The study will be conducted on kidney cancer patients at the University Hospital in Uppsala. At the same time, the company secures substantial financing to complete the clinical trial.
Scientists at the Whitehead Institute for Biomedical Research and the National University of Singapore have discovered the first microRNA (miRNA) capable of directly tamping down the activity of the well known tumor-suppressor gene, p53, While p53 functions to prevent tumor formation, the p53 gene is thought to malfunction in more than 50% of cancerous tumors.
Evolution Benefits and Lighthouse1 announced today that they have completed merging their companies to create Evolution1. Evolution1 offers the nation's most comprehensive electronic payment, on-premise and cloud computing solutions for the administration of flexible spending accounts (FSAs), health savings accounts (HSAs), health reimbursement accounts (HRAs), VEBAs, wellness and transit plans.
Improving the sense of touch and motor skills without active training - what sounds impossible, does actually work. Neuroscientists at the Ruhr-Universität Bochum have developed a glove that uses weak electrical pulses to stimulate the nerve fibres that connect the hands with the brain.
To understand both the correlates of protection induced by vaccinations and the necessary immune responses to manage the COVID-19, researchers from Singapore used an alternative method to closely evaluate the kinetics and magnitude of specific T cell responses to SARS-CoV-2 infection. Their work was posted to the bioRxiv* preprint server while awaiting peer review.
› Verified 4 days ago
| Entity Name | Waters Edge Dermatology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134148992 PECOS PAC ID: 6901893155 Enrollment ID: O20040428001535 |
News Archive
Immunicum, which is developing cancer vaccines, has received approval from the Swedish Medical Products Agency to start its first clinical trial. The study will be conducted on kidney cancer patients at the University Hospital in Uppsala. At the same time, the company secures substantial financing to complete the clinical trial.
Scientists at the Whitehead Institute for Biomedical Research and the National University of Singapore have discovered the first microRNA (miRNA) capable of directly tamping down the activity of the well known tumor-suppressor gene, p53, While p53 functions to prevent tumor formation, the p53 gene is thought to malfunction in more than 50% of cancerous tumors.
Evolution Benefits and Lighthouse1 announced today that they have completed merging their companies to create Evolution1. Evolution1 offers the nation's most comprehensive electronic payment, on-premise and cloud computing solutions for the administration of flexible spending accounts (FSAs), health savings accounts (HSAs), health reimbursement accounts (HRAs), VEBAs, wellness and transit plans.
Improving the sense of touch and motor skills without active training - what sounds impossible, does actually work. Neuroscientists at the Ruhr-Universität Bochum have developed a glove that uses weak electrical pulses to stimulate the nerve fibres that connect the hands with the brain.
To understand both the correlates of protection induced by vaccinations and the necessary immune responses to manage the COVID-19, researchers from Singapore used an alternative method to closely evaluate the kinetics and magnitude of specific T cell responses to SARS-CoV-2 infection. Their work was posted to the bioRxiv* preprint server while awaiting peer review.
› Verified 4 days ago
| Entity Name | Aqua Dermatology Of Florida, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538270335 PECOS PAC ID: 1153390414 Enrollment ID: O20041002000097 |
News Archive
Immunicum, which is developing cancer vaccines, has received approval from the Swedish Medical Products Agency to start its first clinical trial. The study will be conducted on kidney cancer patients at the University Hospital in Uppsala. At the same time, the company secures substantial financing to complete the clinical trial.
Scientists at the Whitehead Institute for Biomedical Research and the National University of Singapore have discovered the first microRNA (miRNA) capable of directly tamping down the activity of the well known tumor-suppressor gene, p53, While p53 functions to prevent tumor formation, the p53 gene is thought to malfunction in more than 50% of cancerous tumors.
Evolution Benefits and Lighthouse1 announced today that they have completed merging their companies to create Evolution1. Evolution1 offers the nation's most comprehensive electronic payment, on-premise and cloud computing solutions for the administration of flexible spending accounts (FSAs), health savings accounts (HSAs), health reimbursement accounts (HRAs), VEBAs, wellness and transit plans.
Improving the sense of touch and motor skills without active training - what sounds impossible, does actually work. Neuroscientists at the Ruhr-Universität Bochum have developed a glove that uses weak electrical pulses to stimulate the nerve fibres that connect the hands with the brain.
To understand both the correlates of protection induced by vaccinations and the necessary immune responses to manage the COVID-19, researchers from Singapore used an alternative method to closely evaluate the kinetics and magnitude of specific T cell responses to SARS-CoV-2 infection. Their work was posted to the bioRxiv* preprint server while awaiting peer review.
› Verified 4 days ago
| Entity Name | Mid-florida Dermatology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619018561 PECOS PAC ID: 1254233786 Enrollment ID: O20051018000717 |
News Archive
Immunicum, which is developing cancer vaccines, has received approval from the Swedish Medical Products Agency to start its first clinical trial. The study will be conducted on kidney cancer patients at the University Hospital in Uppsala. At the same time, the company secures substantial financing to complete the clinical trial.
Scientists at the Whitehead Institute for Biomedical Research and the National University of Singapore have discovered the first microRNA (miRNA) capable of directly tamping down the activity of the well known tumor-suppressor gene, p53, While p53 functions to prevent tumor formation, the p53 gene is thought to malfunction in more than 50% of cancerous tumors.
Evolution Benefits and Lighthouse1 announced today that they have completed merging their companies to create Evolution1. Evolution1 offers the nation's most comprehensive electronic payment, on-premise and cloud computing solutions for the administration of flexible spending accounts (FSAs), health savings accounts (HSAs), health reimbursement accounts (HRAs), VEBAs, wellness and transit plans.
Improving the sense of touch and motor skills without active training - what sounds impossible, does actually work. Neuroscientists at the Ruhr-Universität Bochum have developed a glove that uses weak electrical pulses to stimulate the nerve fibres that connect the hands with the brain.
To understand both the correlates of protection induced by vaccinations and the necessary immune responses to manage the COVID-19, researchers from Singapore used an alternative method to closely evaluate the kinetics and magnitude of specific T cell responses to SARS-CoV-2 infection. Their work was posted to the bioRxiv* preprint server while awaiting peer review.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert E Weltman, MD 5210 Webb Rd, Tampa, FL 33615-4518 Ph: (813) 882-9986 | Dr Robert E Weltman, MD 131 N Oakwood Ave Ste 135, Brandon, FL 33510-4629 Ph: (813) 440-5544 |
News Archive
Immunicum, which is developing cancer vaccines, has received approval from the Swedish Medical Products Agency to start its first clinical trial. The study will be conducted on kidney cancer patients at the University Hospital in Uppsala. At the same time, the company secures substantial financing to complete the clinical trial.
Scientists at the Whitehead Institute for Biomedical Research and the National University of Singapore have discovered the first microRNA (miRNA) capable of directly tamping down the activity of the well known tumor-suppressor gene, p53, While p53 functions to prevent tumor formation, the p53 gene is thought to malfunction in more than 50% of cancerous tumors.
Evolution Benefits and Lighthouse1 announced today that they have completed merging their companies to create Evolution1. Evolution1 offers the nation's most comprehensive electronic payment, on-premise and cloud computing solutions for the administration of flexible spending accounts (FSAs), health savings accounts (HSAs), health reimbursement accounts (HRAs), VEBAs, wellness and transit plans.
Improving the sense of touch and motor skills without active training - what sounds impossible, does actually work. Neuroscientists at the Ruhr-Universität Bochum have developed a glove that uses weak electrical pulses to stimulate the nerve fibres that connect the hands with the brain.
To understand both the correlates of protection induced by vaccinations and the necessary immune responses to manage the COVID-19, researchers from Singapore used an alternative method to closely evaluate the kinetics and magnitude of specific T cell responses to SARS-CoV-2 infection. Their work was posted to the bioRxiv* preprint server while awaiting peer review.
› Verified 4 days ago
Jerry Leo Hedrick, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 500 Vonderburg Drive, Ste 115w, Brandon, FL 33511 Phone: 813-685-0306 Fax: 813-651-1026 | |
Dr. Nancy S Ling, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 305 Bryan Rd, Suite 5 & 6, Brandon, FL 33511 Phone: 813-689-2054 Fax: 813-654-5640 | |
Dr. Kathleen M Colorado, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 507 Oakfield Dr, Brandon, FL 33511 Phone: 813-661-6667 | |
Dr. Brittany Erin Hearn, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 621 Medical Care Dr, Brandon, FL 33511 Phone: 813-657-3330 Fax: 813-657-3348 | |
Mr. Edward B Lack, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 540 Medical Oaks Ave, Suite 102, Brandon, FL 33511 Phone: 813-651-1991 Fax: 813-651-1401 | |
Dr. Susan Lynn Malane, D.O. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 116 S Montclair Ave, Brandon, FL 33511 Phone: 813-685-7714 Fax: 813-685-0113 | |
Michael D. Tharp, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1104 Kyle Wood Ln, Brandon, FL 33511 Phone: 813-948-7550 Fax: 813-948-7566 |